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It has been proposed that immune dysfunction in pso-
riasis is a consequence of aberrent cyclic nucleotide 
metabolism. We have examined cyclic AMP responses to 
isoprenaline, histamine, and prostaglandin E 2 in periph-
eral blood mononuclear leukocytes from patients with 
psoriasis, in the presence and absence of a potent cyclic 
AMP phosphodiesterase inhibitor. Stimulated and basal 
cyclic AMP levels in mononuclear leukocytes from pso-
riatics did not differ from those observed in mononu-
clear leukocytes from normal subjects, irrespective of 
the stimulant employed, either in the presence or in the 
absence of the phosphodiesterase inhibitor. These find-
ings do not support the hypothesis that psoriasis is as-
sociated with either impaired beta-adrenergic reactivity 
or a more generalized abnormality of mononuclear leu-
kocyte cyclic nucleotide metabolism. 
Enhanced immunoglobulin production [1], a decreased re-
sponse of peripheral blood lymphocytes to mitogen [2], and a 
decreased proportion of circulating suppressor T -lymphocytes 
[3] have been considered as indicators of immune dysfunction 
in psoriasis. It has been proposed that this is a manifestation 
of aberrent cyclic nucleotide metabolism [ 4]. In psoriasis, most 
studies demonstrating abnormalities in cyclic nucleotide me-
tabolism have utilized epidermal cells [5- 8], and it has been 
suggested that such abnormalities also occur in peripheral blood 
lymphocytes [4] . More recently, however, the concept of ab-
normal lymphocyte function has been questioned, since normal 
proportions of circu lating subpopulations of T-lymphocytes 
have been demonstrated in psoriasis [9,10] . In the present 
study, cyclic adenosine monophosphate (cyclic AMP) responses 
to isoprenaline, histamine, and prostaglandin E 2, in the pres-
ence and absence of a potent cyclic AMP phosphodiesterase 
inhibitor, have been compared in peripheral blood mononuclear 
leukocytes from patients with psoriasis and normal volunteers. 
PATIENTS, MATERIALS, AND METHODS 
Twelve patients with typical psoriatic plaques (8 males and 4 females; 
mean age, 29.2 years) and 16 healthy, nonatopic volunteers (9 males 
and 7 females; mean age, 27.4 years) were studied. Prior to investiga-
tion , patients had not received therapy (topical or systemic) for a period 
of at least 2 weeks. None had received adrenergic drugs and normal 
volunteers were taking no concurrent medications. Severity of the sk in 
lesions was graded as mild, moderate, or severe (equivalent to a score 
of 1, 2, or 3, respectively) for erythema, degree of scali ng, and indura-
tion, and the mean score used as an index of disease severity. By this 
assessment, there were 3 patients with mild, 6 patients with moderate, 
and 3 patients with severe psoriasis. 
Heparinized venous blood samples, collected between 9:00 and 10:00 
AM, were diluted with phosphate-buffered saline and layered onto 
Ficoll-Paque (Pharmacia). After ce nt rifugation at 400 g for 40 min, the 
mononuclear cell layer was removed, washed, suspended in Hanks' 
buffer (Gibco Biocult) , and the cells counted. This cell population 
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comprised 70-90% lymphocytes, the remainder being mainly mono-
cytes. 
Duplicate aliquots (106 ce lls/ml ) were stimulated, in the presence 
and absence of a potent cyclic AMP phosphodiesterase inhibi tor (ICI 
63197) at 37"C for 10 min. Reagents were dissolved in Han ks' buffer 
and added to the incubation tubes to give the following final concen-
t rations; 10-'• M and 10-a M isoprenaline (Sigma), 10- ' M histamine 
(Sigma), and 1.1 x 10-·• M prostaglandin E2 (Sigma). Basal cyclic AMP 
levels were determined from tubes to which buffer alone had been 
added to the cells. To terminate the response, tubes were immersed in 
boiling water for 10 min. Samples were stored at -20"C, and cyclic 
AMP levels were determined in duplicale, by radioimmunoassay (New 
England Nuclear RIA kit: nonacetylated measu rement). 
Student's l-test was employed for statistical comparison, unpaired 
observations being used for comparison between groups and paired 
obse rvations for within-subject analysis. 
RESULTS 
The basal cyclic AMP content of cells from psoriatic patients 
was not different from that of normal cells (Table I) . In 
mononuclear leukocytes from psoriatic patients, isoprenaline, 
histamine, and prostaglandin E~ all produced a significant 
elevation of cyclic AMP (p < 0.0005) and both basal and 
stimulated levels of cyclic AMP were higher in the presence of 
the cyclic AMP phosphodiesterase inhibitor (ICI 63197). Cor-
responding data for mononuclear leukocytes from normal sub-
jects showed an essentially similar pattern. When responses 
are expressed as the mean of the differences between stimulated 
and basal cyclic AMP levels, the magnitude of responses in 
peripheral blood mononuclear leukocytes from psoriatics did 
not differ from those observed in mononuclear leukocytes from 
normal subjects, irrespective of the stimulant employed, either 
in the presence or in the absence of the phosphodiesterase 
inhibitor (Figs 1, 2). 
DISCUSSION 
In psoriasis, impaired beta-adrenergic reactivity has been 
inferred from the finding that, in comparison to normal skin, 
involved psoriatic skin shows a reduced responsiveness to epi-
nephrine (adrenaline) [11]. In the same study, cyclic AMP 
responses to prostaglandin E" were also reported to be impaired, 
although responses to AMP or adenosine were normal, whereas 
responses to histamine were enhanced. Not all studies concur 
with these observations, and there have been reports of low, 
normal, or high cyclic AMP levels in lesional epidermis [5,6, 
8]. A reduction in the cyclic AMP:cyclic GMP ratio in lesional 
epidermis has also been reported and attributed to a decrease 
in adenylate cyclase activity in proliferating epidermal cells 
[7,8]. Alternatively, reduced cyclic AMP levels may be a con-
sequence of increased phosphodiesterase activity, which has 
also been reported in epidermal slices from lesional skin in 
psoriasis [12]. 
The finding of normal basal cyclic AMP levels in mononu-
clear leukocytes from patients with psoriasis contrasts with 
previous reports of decreased basal cyclic AMP levels in mono-
nuclear leukocytes from patients with psoriasis [ 4,13]. Such 
discrepancies may reflect the dynamic nature of cyclic AMP 
levels in vivo, and it is probably more relevant to measure the 
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responses of mononuclear leukocyte adenylate cyclase to stim-
ulation. As with basal cyclic AMP levels, responses to beta-
adrenergic, histamine, and prostaglandin stimulation were sim-
ilar to those observed in peripheral blood mononuclear leuko-
cytes from normal subjects. The failure to detect such a defect 
cannot be assigned to our experimental conditions, since in a 
parallel study of patients with atopic eczema, we found that in 
the presence of the phosphodiesterase inhibitor, cyclic AMP 
responses to isoprenaline and prostaglandin E~ in peripheral 
blood mononuclear leukocytes from atopic patients were sig-
nificantly lower than in peripheral blood mononuclear leuko-
cytes from normal subjects. Such differences were exaggerated 
by omission of a phosphodiesterase inhibitor, in which circum-
stance, the cyclic AMP response to histamine was also impaired 
[14]. 
The present findings do not support the concept that pso-
riasis is associated with impaired beta-adrenergic reactivity nor 
do they indicate a more generalized abnormality of cyclic nu-
cleotide metabolism in mononuclear leukocytes. More recent 
studies [9,10] ofT -lymphocyte subpopulations have been una-
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TABLE I. Mean cyclic AMP levels 
Controls 
(n = 16) 
15.0 ± 1.8 
32.1 ± 3.1 
34 .1 ± 4.2 
40.3 ± 3.6 
53.4 ± 5.2 
6.6 ± 0.9 
11.2 ± 3.7 
13.0 ± 1.5 
20.1 ± 2.3 
26.8 ± 3.0 
Psoriasis 
(n = 12) 
13.7 ± 2.8 
33.3 ± 4.1 
30.8 ± 3.9 
37.8 ± 4.2 
60.8 ± 6.6 
8.8 ± 1.2 
16.1 ± 2.5 
18.5 ± 3.3 
21.1 ± 4.0 
32.0 ± 4.2 
Mean cyclic AMP levels (pmol per 106 ce lls± SEM) for unstimulated 
(basal) samples, and afte r stimulation with isoprenaline (10- 5 M and 
10- 3 M), histamine (lo-·• M) , and prostaglandin E2 (1.1 X 10-·• M) , in 
the presence and absence of the phosphodiesterase inhibitor (PDEI, 
ICI 63197) in contro l subjects and pat ients with psoriasis. 
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FIG 1. Cyclic AMP responses: mean of stimulated less basal levels 
(pmol per 106 ce lls ± SEM) in control 0 and psoriatic • subjects in 
t h e presence of the phosphodiesterase inhibitor. 
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FIG 2. Cyclic AMP responses: mean of stimulated less basal levels 
(pmol per 106 ce lls ± SEM) in cont rol 0 and psoriatic • subjects in 
the absence of t he phosphodiesterase inhibitor. 
ble to confirm abnormal proportions of T -suppressor cells in 
psoriasis. We would suggest t hat the evidence for immune 
dysfunction in psoriasis merits reappraisal. 
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